Zühlke
Zühlke Ventures AG is the venture capital arm of Zühlke Technology Group AG, based in Zurich, Switzerland, with an additional office in Porto, Portugal. Established in 2011, it specializes in financing early-stage start-ups and providing growth capital, primarily in the healthtech, technology, and medical devices sectors. The firm focuses on investments in Switzerland, the United States, and German-speaking Europe, including Austria and Germany. Zühlke Ventures typically invests between CHF0.5 million and CHF1 million in companies with an enterprise value ranging from CHF0.5 million to CHF5 million. Acting as both investors and co-entrepreneurs, they hold minority stakes and invest from their own capital, aiming for exits within six to ten years through trade sales. Zühlke has a long history, having been founded in 1968, and operates local teams across several countries, facilitating the entire business innovation process from idea to market success.
Evismo AG is a provider of web-based remote vital signs monitoring services, focusing on timely diagnosis for patients with cardiac arrhythmias, sleep apnea, sleep disorders, and stress. Founded in 2018 and headquartered in Zurich, Switzerland, the company offers an extended online ECG service known as CardioFlex. Its clientele includes general practitioners, cardiologists, clinics, hospitals, and other healthcare professionals. Evismo aims to enhance healthcare delivery by capturing previously unmeasured data, thus facilitating improvements in diagnostics, prevention, therapy, and treatment outcomes in a cost-effective and patient-oriented manner.
Koya Medical, Inc. is a company based in Oakland, California, founded in 2018. It focuses on developing a connected wearable platform designed to address the significant unmet needs in the treatment of cancer-related chronic lymphedema and venous diseases. The technology aims to provide a drug-free solution for patients suffering from these conditions, enhancing their quality of life through innovative medical devices.
Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.
Swisstom AG, based in Landquart, Switzerland, specializes in the development and manufacture of innovative medical devices focused on monitoring lung and heart function. The company offers advanced systems that facilitate life-saving treatments for patients in intensive care and during general anesthesia. Notably, Swisstom's products include the Swisstom BB2, designed for monitoring lung function in ICU patients undergoing mechanical ventilation, and the elisa 800VIT, which visualizes ventilation-related complications and allows for immediate intervention at the ventilator. Utilizing non-radiating Electrical Impedance Tomography (EIT), Swisstom's bedside imaging technology provides continuous, real-time insights into regional organ function, setting it apart from traditional methods. Established in 2009, Swisstom AG operates as a subsidiary of SenTec AG and aims to enhance patient care through its cutting-edge monitoring solutions.
DSwiss AG develops a secure digital services for both individuals and companies worldwide. The company offers digital safes, mailboxes for bank document delivery and secure exchange platforms for financial advisors and customers. It also offers individual solutions, which include IT services for projects ranging from planning phase through to implementation and development. The company was founded in 2008 and is based in Zurich, Switzerland.
DistalMotion Sàrl, founded in 2012 and headquartered in Lausanne, Switzerland, specializes in developing medical devices for minimally invasive surgeries. The company focuses on creating surgical robotic technology that simplifies surgical processes, specifically in dissection and suturing. Its innovative robotic device enhances laparoscopic procedures in the abdominal cavity, allowing healthcare professionals to deliver improved patient care. By bridging the gap between surgical robotics and traditional laparoscopy, DistalMotion aims to transform the landscape of minimally invasive surgery.
Leman Micro Devices SA, incorporated in 2013 and based in Lausanne, Switzerland, specializes in developing innovative technology for future smartphones. The company has introduced the V-Sensor health sensor and accompanying application, which offers a cuffless and calibration-free solution for measuring vital health metrics such as blood pressure, body temperature, blood oxygen saturation, heart rate, and respiration rate with medical accuracy. Leman Micro Devices' sensor and software system are designed to comply with international medical standards and are compact and cost-effective, enabling integration into smartphones, wearables, and other mobile devices.
Tenon Technology
Series A in 2013
Lower back pain is one of the most common types of back pain in adults and can be debilitating. There are many different diagnoses, but the sacroiliac (SI) joint is involved in more than 15% of cases. The joint connects the hip bones to the spinal column and as a consequence experiences constant strain. Inflammation of the SI joint is correspondingly painful. In chronic cases which are not well controlled by physiotherapy and painkillers, surgical fixation of the joint remains the only option. The market for SI joint fixation is large and is growing disproportionately compared to the back orthopaedic market as a whole
Swisstom AG, based in Landquart, Switzerland, specializes in the development and manufacture of innovative medical devices focused on monitoring lung and heart function. The company offers advanced systems that facilitate life-saving treatments for patients in intensive care and during general anesthesia. Notably, Swisstom's products include the Swisstom BB2, designed for monitoring lung function in ICU patients undergoing mechanical ventilation, and the elisa 800VIT, which visualizes ventilation-related complications and allows for immediate intervention at the ventilator. Utilizing non-radiating Electrical Impedance Tomography (EIT), Swisstom's bedside imaging technology provides continuous, real-time insights into regional organ function, setting it apart from traditional methods. Established in 2009, Swisstom AG operates as a subsidiary of SenTec AG and aims to enhance patient care through its cutting-edge monitoring solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.